Skip to content

Form 4 filed by George Simeon

George Simeon filed this Form 4 on ADARx Pharmaceuticals, Inc. with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-09-30 01:43:23 UTC.

Accession
0001193125-26-408061
Filed
2026-09-29
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Issuer and reporting owners

Issuer: ADARx Pharmaceuticals, Inc. (CIK 1802369)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-09-28C converted+3,334,9383,334,938I See Note 2
Common Stock 2026-09-28C converted+1,113,6664,448,604I See Note 2
Common Stock 2026-09-28C converted+512,8974,961,501I See Note 2
Common Stock 2026-09-28P bought+592,593$175,554,094I See Note 2
Common Stock 2026-09-28C converted+1,538,6911,538,691I See Note 3
Common Stock 2026-09-28P bought+414,814$171,953,505I See Note 3
Common Stock 2026-09-28C converted+1,667,4681,667,468I See Note 4
Common Stock 2026-09-28C converted+169,0011,836,469I See Note 4
Common Stock 2026-09-28P bought+592,593$17592,593I See Note 5
Series B Preferred Stock derivative2026-09-28C converted-3,907,547$00I See Note 2
Series B-1 Preferred Stock derivative2026-09-28C converted-1,304,883$00I See Note 2
Series C Preferred Stock derivative2026-09-28C converted-600,962$00I See Note 2
Series C Preferred Stock derivative2026-09-28C converted-1,802,885$00I See Note 3
Series B Preferred Stock derivative2026-09-28C converted-1,953,773$00I See Note 4
Series B-1 Preferred Stock derivative2026-09-28C converted-198,019$00I See Note 4